FF:0000625: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|is_obsolete= | |is_obsolete= | ||
|located_in= | |located_in= | ||
|name=experimental infection | |name=experimental infection sample | ||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|obo_creation_date=2011-08-29T11:23:40Z | |obo_creation_date=2011-08-29T11:23:40Z | ||
Latest revision as of 16:57, 12 September 2014
outline
- id: FF:0000625
- name: experimental infection sample
- namespace: FANTOM5
- def: "A treatment whereinfectious agents, or compunds derived frmo infectious agents, are administered." [GOC:tfm]
- created_by: tmeehan
- creation_date: 29 August 2011 11:23:40
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | EFO:0000727(treatment) |
|---|
Children
| is a: | FF:0000335 (LPS treatment sample),FF:0000628 (Bacillus Calmette-Guerin treatment sample),FF:0000630 (beta-glucan treatment sample),FF:0000631 (trehalose dimycolate (TDM) treatment sample),FF:0000632 (group A streptococci treatment sample),FF:0000633 (Salmonella treatment sample),FF:0000634 (Cryptococcus treatment sample),FF:0000635 (Candida treatment sample),FF:0000647 (udorn influenza infection sample),FF:0000648 (mock infection sample),FF:10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C)),FF:10453-106G3 (cord blood derived cell line:COBL-a 24h infection) |
|---|
FF Samples
Human
- 10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C))
- 10453-106G3 (cord blood derived cell line:COBL-a 24h infection)
